Abstract:BACKGROUND:Prediction of drug-target interaction (DTI) is an essential step for drug discovery and drug reposition. Traditional methods are mostly time-consuming and labor-intensive, and deep learning-based methods address these limitations and are applied to engineering. Most of the current deep learning methods employ representation learning of unimodal information such as SMILES sequences, molecular graphs, or molecular images of drugs. In addition, most methods focus on feature extraction from drug and target alone without fusion learning from drug-target interacting parties, which may lead to insufficient feature representation.MOTIVATION:In order to capture more comprehensive drug features, we utilize both molecular image and chemical features of drugs. The image of the drug mainly has the structural information and spatial features of the drug, while the chemical information includes its functions and properties, which can complement each other, making drug representation more effective and complete. Meanwhile, to enhance the interactive feature learning of drug and target, we introduce a bidirectional multi-head attention mechanism to improve the performance of DTI.RESULTS:To enhance feature learning between drugs and targets, we propose a novel model based on deep learning for DTI task called MCL-DTI which uses multimodal information of drug and learn the representation of drug-target interaction for drug-target prediction. In order to further explore a more comprehensive representation of drug features, this paper first exploits two multimodal information of drugs, molecular image and chemical text, to represent the drug. We also introduce to use bi-rectional multi-head corss attention (MCA) method to learn the interrelationships between drugs and targets. Thus, we build two decoders, which include an multi-head self attention (MSA) block and an MCA block, for cross-information learning. We use a decoder for the drug and target separately to obtain the interaction feature maps. Finally, we feed these feature maps generated by decoders into a fusion block for feature extraction and output the prediction results.CONCLUSIONS:MCL-DTI achieves the best results in all the three datasets: Human, C. elegans and Davis, including the balanced datasets and an unbalanced dataset. The results on the drug-drug interaction (DDI) task show that MCL-DTI has a strong generalization capability and can be easily applied to other tasks.

MSDAFL: molecular substructure-based dual attention feature learning framework for predicting drug-drug interactions

MASMDDI: multi-layer adaptive soft-mask graph neural network for drug-drug interaction prediction

MSFF-MA-DDI: Multi-Source Feature Fusion with Multiple Attention blocks for predicting Drug-Drug Interaction events

Molecular Substructure-Aware Network for Drug-Drug Interaction Prediction

An effective framework for predicting drug–drug interactions based on molecular substructures and knowledge graph neural network

AttentionDDI: Siamese attention-based deep learning method for drug–drug interaction predictions

MLRDA: A Multi-Task Semi-Supervised Learning Framework for Drug-Drug Interaction Prediction

MDF-SA-DDI: predicting drug–drug interaction events based on multi-source drug fusion, multi-source feature fusion and transformer self-attention mechanism

Multi-View Substructure Learning for Drug-Drug Interaction Prediction

Learning self-supervised molecular representations for drug–drug interaction prediction

AMDE: a novel attention-mechanism-based multidimensional feature encoder for drug–drug interaction prediction

SSI–DDI: substructure–substructure interactions for drug–drug interaction prediction

RGDA-DDI: Residual graph attention network and dual-attention based framework for drug-drug interaction prediction

MCL-DTI: Using Drug Multimodal Informationand Bi-directional Cross-Attention Learningmethod for Predicting Drug-Target Interaction

A Molecular Fragment Representation Learning Framework for Drug–Drug Interaction Prediction

DSN-DDI: an accurate and generalized framework for drug–drug interaction prediction by dual-view representation learning

Molecular Structure-Based Double-Central Drug-Drug Interaction Prediction

SSF-DDI: a deep learning method utilizing drug sequence and substructure features for drug–drug interaction prediction

MCFF-MTDDI: multi-channel feature fusion for multi-typed drug–drug interaction prediction

Predicting drug-drug interactions using multi-modal deep auto-encoders based network embedding and positive-unlabeled learning

Directed graph attention networks for predicting asymmetric drug–drug interactions